NCT06187246

Brief Summary

A randomized controlled trial was conducted for testing the efficacy of a novel avatar-based intervention (IG), that was compared with a control group (CG) for women with female orgasmic disorder (FOD). Participants were 31 women who were randomly assigned to the intervention or the control conditions. Intervention was based on the cognitive behavioral therapy approach (treatment with the most empirical evidence) and previous literature about FOD. It consisted of 12 weekly online individual sessions and aimed at improving the FOD diagnosis, sexual variables, and variables that are known to affect orgasm consecution. Control group was based on minimum therapeutic contact. Changes over time in the assessed variables were analyzed using linear mixed models, considering treatment group, measurement time point, and group-by-time interactions as fixed effects. Effect sizes were computed (Cohen's d; number needed to treat - NNT; reliable change index - RCI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 5, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 2, 2024

Completed
Last Updated

January 2, 2024

Status Verified

December 1, 2023

Enrollment Period

1.4 years

First QC Date

December 5, 2023

Last Update Submit

December 29, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Sexual satisfaction assessed by the Golombok Rust Inventory of Sexual Satisfaction

    Sexual satisfaction is the feeling of pleasure that one has when the sexual desire has been fulfilled. The Golombok Rust Inventory of Sexual Satisfaction has minimum-maximum values of 0-112; higher scores mean a worse outcome. The cut-off for determining significant levels of Sexual Satisfaction is 60 (scores equal to or above 60 indicate the existence of a sexual problem).

    From baseline to the end of the treatment at 12 weeks + 1 month-follow-up and 3 month-follow-up

  • Sexual functionassessed by the Female Sexual Function Index

    Sexual function refers to the capacity of having a satisfactory sexual life. The Female Sexual Function Index has minimum-maximum values of 19-95; higher scores mean a better outcome. The cut-off for determining significant levels of this variable is 55 (scores equal to or below 55 indicate poor Sexual Function).

    From baseline to the end of the treatment at 12 weeks + 1 month-follow-up and 3 month-follow-up

  • Initiative and Sexual Communication assessed by the Female Sexual Function Questionnaire

    Initiative and Sexual Communication is the proactive and consensual expression of one's sexual desires, interests, and intentions within the context of a sexual relationship or encounter. The Female Sexual Function Questionnaire has minimum-maximum values of 14-70; higher scores mean a better outcome. The cut-off for determining significantly low levels of this variable are scores equal to or lower than 25.

    From baseline to the end of the treatment at 12 weeks + 1 month-follow-up and 3 month-follow-up

Secondary Outcomes (3)

  • Sexual self-esteem assessed by the Rosenberg Self-Esteem Scale

    From baseline to the end of the treatment at 12 weeks + 1 month-follow-up and 3 month-follow-up

  • Sex-guilt assessed by the Brief Mosher Sex-Guilt Scale

    From baseline to the end of the treatment at 12 weeks + 1 month-follow-up and 3 month-follow-up

  • Sexual anxiety by the Sexual Anxiety scale of the Expanded Sexual Arousability Inventory

    From baseline to the end of the treatment at 12 weeks + 1 month-follow-up and 3 month-follow-up

Study Arms (2)

Avatar-based Intervention Group

EXPERIMENTAL

Treatment was based on the CBT approach and previous literature about FOD. It consisted of 12 weekly online individual sessions, which were administered once a week (total duration = 3 months) and lasted about 60 minutes each.

Behavioral: Avatar-based intervention

Minimal support control group

ACTIVE COMPARATOR

It consisted in individual informative talks, during which they were provided with information about female orgasm (e.g., what is an orgasm, neuronal orgasm, factors that may influence consecution, sexual response), masturbatory techniques (e.g., key elements to achieve pleasure, anatomy of the female genitalia, pleasure areas) and techniques to focus attention on one's body (i.e., an important factor to pleasure). Participants received three individual sessions once a month, and had a duration of one hour.

Other: Individual informative talks

Interventions

Intervention was aimed at improving sexual variables (sexual satisfaction, sexual function, and initiative and sexual communication), and variables that are known to affect orgasm consecution (sexual self-esteem, sex-guilt, and sexual anxiety). To achieve this objective, it focused on fostering participants' abilities to increase their levels of sexual stimulation, and the engagement in personal values, along with identifying and modifying dysfunctional thoughts about sexuality. The techniques used included psychosexual education, cognitive restructuring, virtual exposure, sexual stimulation, and engagement in personal values from the acceptance and commitment therapy (ACT) perspective. It was delivered via a metaverse: Second Life.

Avatar-based Intervention Group

Participants were provided with information about female orgasm (e.g., what is an orgasm, neuronal orgasm, factors that may influence consecution, sexual response), masturbatory techniques (e.g., key elements to achieve pleasure, anatomy of the female genitalia, pleasure areas) and techniques to focus attention on one's body (i.e., an important factor to pleasure). Participants received three individual sessions once a month, and had a duration of one hour.

Minimal support control group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Present the characteristics to diagnose female orgasm disorder after a clinic assessment (considering natural characteristics of the women's sexual response cycle (Conn \& Hodges, 2022) based on the DSM-5 criteria.
  • Provide a medical check to prove the absence of physical factors that may be the cause of the orgasm dysfunction, as this is the first part to diagnose FOD.
  • Be at least 18 years old (adult).
  • Have access to a computer with the characteristics to run Second Life and internet connection.

You may not qualify if:

  • Present a diagnosis of a physical condition that may be the cause of the orgasm dysfunction (e.g., genital lesions, systemic and hormonal factors, vulvovaginal atrophy).
  • Presence of other psychological pathology (e.g., depression, trauma) that may be the cause of the orgasm dysfunction.
  • Have alcohol dependence (i.e., evaluated during the clinical assessment, according to the diagnostic criteria from the DSM-5, to determine if the individual meets the criteria for an alcohol use disorder diagnosis).
  • Drug use, including medication that is known to cause sexual difficulties (e.g., selective serotonin reuptake inhibitors (SSRIs), that are a particularly common drug cause of sexual dysfunction.
  • Have participated in a previous psychological intervention in the last year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rey Juan Carlos University

Alcorcón, Madrid, 28922, Spain

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized control trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

December 5, 2023

First Posted

January 2, 2024

Study Start

January 1, 2022

Primary Completion

June 1, 2023

Study Completion

June 1, 2023

Last Updated

January 2, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations